CompoSecure, Inc. today announced that its stockholders have approved the issuance of shares of CompoSecure Class A Common Stock in connection with the proposed business combination with Husky Technologies Limited (“Husky”)
Rhea-AI Summary
CompoSecure (NYSE: CMPO) announced that its stockholders approved the issuance of CompoSecure Class A common stock to effect a proposed business combination with Husky Technologies Limited.
The company said the transaction is expected to close in January 2026, subject to customary closing conditions and regulatory approvals. Final voting results will be reported in a Form 8-K filed with the SEC.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
CMPO was up 0.78% pre-news with mixed peer moves: PRLB +0.62%, IIIN +2.69%, RYI +1.19%, WOR +0.48%, ESAB -0.16%, indicating stock-specific dynamics rather than a broad sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 03 | Earnings & merger | Positive | +3.4% | Strong 3Q25 metrics and announcement of Husky combination with raised guidance. |
| Oct 27 | Earnings call setup | Neutral | +2.1% | Scheduling Q3 2025 results conference call and webcast details. |
| Oct 09 | Management change | Neutral | -3.7% | Appointment of new CFO with retirement of prior CFO and transition support. |
| Sep 24 | Strategic partnership | Positive | -1.5% | Arculus partnership with N.exchange to add crypto swaps and smart order routing. |
| Sep 08 | Listing transfer | Positive | -2.5% | Transfer of Class A share listing from Nasdaq to NYSE while keeping ticker. |
Recent news shows generally constructive reactions to major strategic and earnings updates, while corporate actions like listing changes have seen more mixed price responses.
Over the last few months, CompoSecure has reported strong 3Q25 results and unveiled the Husky business combination, which saw a +3.42% next-day move. It also scheduled its Q3 earnings call, appointed a new CFO, expanded its Arculus crypto capabilities via a partnership with N.exchange, and transitioned its listing to the NYSE, with varied price reactions. Today’s approval of share issuance for the Husky combination follows the earlier merger proxy and prior announcement of the transaction’s terms and expected closing in Q1 2026.
Market Pulse Summary
This announcement confirms stockholder approval for issuing Class A shares to complete the Husky business combination, moving the transaction closer to its expected closing, subject to regulatory approvals and other customary conditions. It follows detailed terms already outlined in the merger proxy and prior earnings release. Investors may watch upcoming Form 8-K voting disclosures, regulatory clearance milestones, and any updates to financing or integration plans as key markers of execution on this strategic step.
Key Terms
business combination financial
class a common stock financial
regulatory approvals regulatory
form 8-k regulatory
securities and exchange commission regulatory
AI-generated analysis. Not financial advice.
SOMERSET, N.J., Dec. 24, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (NYSE: CMPO) today announced that its stockholders have approved the issuance of shares of CompoSecure Class A Common Stock in connection with the proposed business combination with Husky Technologies Limited (“Husky”). The business combination with Husky is expected to close in January 2026, subject to customary closing conditions, including regulatory approvals.
The final voting results from CompoSecure’s special meeting of stockholders will be set forth in a Form 8-K filed by CompoSecure with the U.S. Securities and Exchange Commission (the “SEC”).
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. Statements that are not historical facts, including statements about demand letters and complaints relating to the transactions, the timing and completion of the transactions, expected benefits, future plans, expectations and opportunities, are forward-looking statements. Forward-looking statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially. Important factors include, among others: (i) the risk that the transactions may not be completed in a timely manner or at all; (ii) the failure to obtain required approvals, including regulatory approvals; (iii) the occurrence of any event that could give rise to termination of the Share Purchase Agreement; (iv) the effect of the announcement, pendency or consummation of the transactions on the parties’ business relationships, operations, financial and accounting matters; (v) risks that the expected benefits of the transactions, including financial projections, estimates and outlook, may not be fully realized or may take longer to realize than expected; (vi) risks related to financing the transactions; (vii) costs related to the transactions; (viii) potential litigation and/or regulatory actions relating to the transactions, including the demand letters and complaints described herein, and otherwise; (ix) general economic, market, industry and competitive conditions; and (x) other risks and uncertainties described in CompoSecure’s filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2024 and subsequent Quarterly Reports on Form 10-Q, which identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date made. CompoSecure undertakes no obligation to update any forward-looking statements, except as required by law.

CompoSecure Investor Relations Contact Sean Mansouri, CFA Elevate IR (720) 330-2829 CMPO@elevate-ir.com